surpass 6 tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6) A) The SURPASS Program (SURPASS1–6).

During weight loss, particularly if dietary protein intake is insufficient (generally aim for 1.0-1.2g/kg/day unless contraindicated), there is a risk of losing lean muscle mass alongside fat tissue

Nature 546, 254258

These two revolutionary medications are transforming the management of weight and type 2 diabetes

Diabetologia 48(7):13391349 Reed JC (1997) Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies

Enter Tirzepatide , a groundbreaking medication reshaping the landscape of weight management

A healthcare provider can help determine the most appropriate treatment based on individual health needs